Enhanced CD24 expression in endometrial carcinoma and its expression pattern in normal and hyperplastic endometrium

Histology and Histopathology

Volumn 24, Issue 3, 2009, Pages 309-316

  Kim, Kyung Hee ^a   Choi, Jong Sun ^b   Kim, Jin Man ^c   Choi, Yoon La ^d   Shin, Young Kee ^e   Lee, Ho Chang ^f   Seong, In Ock ^a   Kim, Bum Kyung ^g   Chae, Seoung Wan ^h   Kim, Seok Hyung ^d  

^a Eulji University   (South Korea)

^b Dongguk University Ilsan Hospital   (South Korea)

^c Chungnam National University College of Medicine   (South Korea)

^d Sungkyunkwan University School of Medicine   (South Korea)

^e Seoul National University   (South Korea)

^f Chungbuk National University College of Medicine   (South Korea)

^g Konyang University College of Medicine   (South Korea)

^h Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

CD24; Endometrial carcinoma; Endometrial hyperplasia; Estrogen receptor; Progesterone receptor

Indexed keywords

CD24 ANTIGEN; ESTROGEN RECEPTOR; MESSENGER RNA; MONOCLONAL ANTIBODY; PARAFFIN; PROGESTERONE RECEPTOR;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CANCER GRADING; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; DOWN REGULATION; ENDOMETRIUM ATROPHY; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH; UPREGULATION; ENDOMETRIUM; ENDOMETRIUM TUMOR; GENE EXPRESSION REGULATION; GENETICS; HYPERPLASIA; METABOLISM; PATHOLOGY;

ANTIGENS, CD24; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RNA, MESSENGER;

EID: 63649119018     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J. and Clarke M.F. (2003). Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 100, 3983-3988.
2. Bergeron C., Ferenczy A. and Shyamala G. (1988). Distribution of estrogen receptors in various cell types of normal, hyperplastic, and neoplastic human endometrial tissues. Lab. Invest. 58, 338-345.
3. Choi Y.L., Kim S.H., Shin Y.K., Hong Y.C., Lee S.J., Kang S.Y. and Ahn G. (2005). Cytoplasmic CD24 expression in advanced ovarian serous borderline tumors. Gynecol. Oncol. 97, 379-386.
4. Choi Y.L., Xuan Y.H., Lee S.J. and Kim S.H. (2006). Enhanced CD24 expression in colorectal cancer correlates with prognostic factors. Kor. J. Pathol. 40, 103-111.
5. Droz D., Zachar D., Charbit L., Gogusev J., Chretein Y. and Iris L. (1990). Expression of the human nephron differentiation molecules in renal cell carcinomas. Am. J. Pathol. 137, 895-905.
6. Fischer G.F., Majdic O., Gadd S. and Knapp W. (1990). Signal transduction in lymphocytic and myeloid cells via CD24, a new member of phosphoinositol-anchored membrane molecules. J. Immunol. 144, 638-641.
7. Fogel M., Friederichs J., Zeller Y., Husar M., Smirnov A., Roitman L., Altevogt P. and Sthoeger Z.M. (1999). CD24 is a marker for human breast carcinoma. Cancer Lett. 143, 87-94.
8. Jackson D., Waibel R., Weber E., Bell J. and Stahel R.A. (1992). CD24, a signal-transducing molecule expressed on human B cells, is a major surface antigen on small cell lung carcinomas. Cancer Res. 52, 5264-5270.
9. Kim S.H., Shin Y.K., Lee K.M., Lee J.S., Yun J.H. and Lee S.M. (2003). An improved protocol of biotinylated tyramine-based immunohistochemistry minimizing nonspecific background staining. J. Histochem. Cytochem. 51, 129-132.
10. Kim S.H., Kook M.C. and Song H.G. (2004a). Optimal conditions for the retrieval of CD4 and CD8 antigens in formalin-fixed, paraffin-embedded tissues. J. Mol. Histol. 35, 403-408.
11. Kim S.H., Kook M.C., Shin Y.K., Park S.H. and Song H.G. (2004b). Evaluation of antigen retrieval buffer systems. J. Mol. Histol. 35, 409-416.
12. Kristiansen G., Denkert C., Schluns K., Dahl E., Pilarsky C. and Hauptmann S. (2002). CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival. Am. J. Pathol. 161, 1215-1221.
13. Kristiansen G., Winzer KJ., Mayordomo E., Bellach J., Schluns K., Denkert C., Dahl E., Pilarsky C., Altevogt P., Guski H. and Dietel M. (2003). CD24 expression is a new prognostic marker in breast cancer. Clin. Cancer Res. 9, 4906-4913.
14. Kristiansen G., Pilarsky C., Pervan J., Stürzebecher B., Stephan C., Jung K., Loening S., Rosenthal A. and Dietel M. (2004). CD24 expression is a significant predictor of PSA relapse and poor prognosis in low grade or organ confined prostate cancer. Prostate 58, 183-192.
15. Kristiansen G., Pilarsky C., Wissmann C., Kaiser S., Bruemmendorf T., Roepcke S., Dahl E., Hinzmann B., Specht T., Pervan J., Stephan C., Loening S., Dietel M. and Rosenthal A. (2005). Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival. J. Pathol. 205, 359-376.
16. Mechtersheimer G., Barth T., Ludwig R., Staudter M. and Moller P. (1993). Differential expression of leukocyte differentiation antigens in small round blue cell sarcomas. Cancer 71, 237-248.
17. Papadimitriou C.S., Athanasiadou S., Stylianidou A., Bai M.K., Demoliatis J. and Stephanou D.G. (1992). Immunohistochemical detection of estrogen receptors on paraffin sections of normal, hyperplatic and carcinomatous endometrium. Oncology 49, 196-202.
18. Parkin D.M., Bray F., Ferlay J. and Pisani P. (2005). Global cancer statistics, 2002. CA. Cancer J. Clin. 55, 74-108.
19. Sinicrope F.A., Ruan S.B., Cleary K.R., Stephens L.C., Lee J.J. and Levin B. (1995). bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res. 55, 237-241.
20. Stingl J., Eirew P., Ricketson I., Shackleton M., Vaillant F., Choi D., Li H.I. and Eaves C.J. (2006). Purification and unique properties of mammary epithelial stem cells. Nature 439, 993-997.
21. Wang R.H. (2006). The new portrait of mammary gland stem cells. Int. J. Biol. Sci. 2, 186-187.
22. Weichert W., Denkert C., Burkhardt M., Gansukh T., Bellach J., Altevogt P., Dietel M. and Kristiansen G. (2005). Cytoplasmic CD24 expression in colorectal cancer independently correlates with shortened patient survival. Clin. Cancer Res. 11, 6574-6581.